FDA Grants Breakthrough Device Designation to Bio-Techne ExoDx™ Prostate Intelliscore™ (EPI) Test View more
Bio-Techne Receives Approval to Offer the ExoDx™ Prostate Intelliscore™ (EPI) Test in New York State View more
Bio-Techne’s New Exosome-Based Liquid Biopsies Helping to Advance Personalized Care in Lung Cancer Diagnostics View more
